IP Verse

Nerve Growth Factor Composition And Powder Injection

Patent No. EP3287139 (titled "Nerve Growth Factor Composition And Powder Injection") was filed by Beijing Staidson Medical Technology on Apr 18, 2016. The application was issued on Aug 11, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DOMPE FARMACEUTICIMay 11, 2022FRAIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3287139

BEIJING STAIDSON MEDICAL TECHNOLOGY
Application Number
EP16782600A
Filing Date
Apr 18, 2016
Status
Revoked
May 10, 2024
Publication Date
Aug 11, 2021
External Links
Slate, Register , Google Patents